Some studies demonstrated that KRAS and GNAS gene mutations occurred in LAMN (22, 23), and patients with high-grade AMN manifested mutations of KRAS and GNAS, along with TP53, as well as ATM (24). The gene discussed is TP53; the disease is adrenomyeloneuropathy.